Key Highlights
- John Potthoff assumes CEO role at RQM+, succeeding Margaret Keegan.
- Margaret Keegan transitions to focus on her role with Linden Capital Partners while remaining on the board.
- Potthoff brings extensive leadership and MedTech expertise, enhancing RQM+’s strategic direction.
Source: Business Wire
Notable Quotes
- “During Margaret’s tenure, she completed three acquisitions and made significant progress in creating an end-to-end MedTech CRO at RQM+,” – John Potthoff, Ph.D., Incoming CEO at RQM+
- “I am extremely proud of the RQM+ team’s many accomplishments,” – Margaret Keegan, Former CEO at RQM+
SoHC's Take
The appointment of John Potthoff as CEO of RQM+ is a strategic move that highlights the company’s commitment to innovation and leadership continuity within the MedTech sector. His previous roles and achievements, especially in global medical device and diagnostics businesses, indicate a promising future for RQM+ in an industry that continues to evolve rapidly. This leadership transition is well-planned, ensuring stability and continued growth, leveraging both Potthoff’s vision and Keegan’s ongoing guidance.
